These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26970280)

  • 21. [Alpha-Synuclein in blood and cerebrospinal fluid of patients with alpha-synucleinopathy].
    Ono K; Yamada M
    Rinsho Byori; 2014 Mar; 62(3):241-5. PubMed ID: 24800499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct Autoimmune Anti-α-Synuclein Antibody Patterns in Multiple System Atrophy and Parkinson's Disease.
    Folke J; Rydbirk R; Løkkegaard A; Salvesen L; Hejl AM; Starhof C; Bech S; Winge K; Christensen S; Pedersen LØ; Aznar S; Pakkenberg B; Brudek T
    Front Immunol; 2019; 10():2253. PubMed ID: 31616427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease.
    Stav AL; Aarsland D; Johansen KK; Hessen E; Auning E; Fladby T
    Parkinsonism Relat Disord; 2015 Jul; 21(7):758-64. PubMed ID: 25971633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias.
    Parnetti L; Chiasserini D; Bellomo G; Giannandrea D; De Carlo C; Qureshi MM; Ardah MT; Varghese S; Bonanni L; Borroni B; Tambasco N; Eusebi P; Rossi A; Onofrj M; Padovani A; Calabresi P; El-Agnaf O
    Mov Disord; 2011 Jul; 26(8):1428-35. PubMed ID: 21469206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CSF α-synuclein does not differentiate between parkinsonian disorders.
    Aerts MB; Esselink RA; Abdo WF; Bloem BR; Verbeek MM
    Neurobiol Aging; 2012 Feb; 33(2):430.e1-3. PubMed ID: 21236518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-synuclein modulates retinal iron homeostasis by facilitating the uptake of transferrin-bound iron: Implications for visual manifestations of Parkinson's disease.
    Baksi S; Tripathi AK; Singh N
    Free Radic Biol Med; 2016 Aug; 97():292-306. PubMed ID: 27343690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ceruloplasmin is increased in cerebrospinal fluid in Alzheimer's disease but not Parkinson's disease.
    Loeffler DA; DeMaggio AJ; Juneau PL; Brickman CM; Mashour GA; Finkelman JH; Pomara N; LeWitt PA
    Alzheimer Dis Assoc Disord; 1994; 8(3):190-7. PubMed ID: 7986488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantification of α-synuclein in cerebrospinal fluid: how ideal is this biomarker for Parkinson's disease?
    Mollenhauer B
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S76-9. PubMed ID: 24262194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid increase of 'brain-type' transferrin in cerebrospinal fluid after shunt surgery for idiopathic normal pressure hydrocephalus: a prognosis marker for cognitive recovery.
    Murakami Y; Matsumoto Y; Hoshi K; Ito H; Fuwa TJ; Yamaguchi Y; Nakajima M; Miyajima M; Arai H; Nollet K; Kato N; Nishikata R; Kuroda N; Honda T; Sakuma J; Saito K; Hashimoto Y
    J Biochem; 2018 Sep; 164(3):205-213. PubMed ID: 29701803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
    Ohrfelt A; Grognet P; Andreasen N; Wallin A; Vanmechelen E; Blennow K; Zetterberg H
    Neurosci Lett; 2009 Feb; 450(3):332-5. PubMed ID: 19022350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunochemical Detection of α-Synuclein Autoantibodies in Parkinson's Disease: Correlation between Plasma and Cerebrospinal Fluid Levels.
    Horvath I; Iashchishyn IA; Forsgren L; Morozova-Roche LA
    ACS Chem Neurosci; 2017 Jun; 8(6):1170-1176. PubMed ID: 28263550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total CSF α-synuclein is lower in de novo Parkinson patients than in healthy subjects.
    Mollenhauer B; Trautmann E; Taylor P; Manninger P; Sixel-Döring F; Ebentheuer J; Trenkwalder C; Schlossmacher MG
    Neurosci Lett; 2013 Jan; 532():44-8. PubMed ID: 23149132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease.
    El-Agnaf OM; Salem SA; Paleologou KE; Curran MD; Gibson MJ; Court JA; Schlossmacher MG; Allsop D
    FASEB J; 2006 Mar; 20(3):419-25. PubMed ID: 16507759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease.
    Shi M; Liu C; Cook TJ; Bullock KM; Zhao Y; Ginghina C; Li Y; Aro P; Dator R; He C; Hipp MJ; Zabetian CP; Peskind ER; Hu SC; Quinn JF; Galasko DR; Banks WA; Zhang J
    Acta Neuropathol; 2014 Nov; 128(5):639-650. PubMed ID: 24997849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. alpha-synuclein from platelets is not phosphorylated at serine 129 in Parkinson's disease and multiple system atrophy.
    Shults CW; Barrett JM; Fontaine D
    Neurosci Lett; 2006 Sep; 405(3):223-5. PubMed ID: 16901642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolution of cerebrospinal fluid total α-synuclein in Parkinson's disease.
    Førland MG; Öhrfelt A; Dalen I; Tysnes OB; Blennow K; Zetterberg H; Pedersen KF; Alves G; Lange J
    Parkinsonism Relat Disord; 2018 Apr; 49():4-8. PubMed ID: 29409704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis.
    Eusebi P; Giannandrea D; Biscetti L; Abraha I; Chiasserini D; Orso M; Calabresi P; Parnetti L
    Mov Disord; 2017 Oct; 32(10):1389-1400. PubMed ID: 28880418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A unique N-glycan on human transferrin in CSF: a possible biomarker for iNPH.
    Futakawa S; Nara K; Miyajima M; Kuno A; Ito H; Kaji H; Shirotani K; Honda T; Tohyama Y; Hoshi K; Hanzawa Y; Kitazume S; Imamaki R; Furukawa K; Tasaki K; Arai H; Yuasa T; Abe M; Arai H; Narimatsu H; Hashimoto Y
    Neurobiol Aging; 2012 Aug; 33(8):1807-15. PubMed ID: 21459485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CSF α-synuclein does not discriminate dementia with Lewy bodies from Alzheimer's disease.
    Reesink FE; Lemstra AW; van Dijk KD; Berendse HW; van de Berg WD; Klein M; Blankenstein MA; Scheltens P; Verbeek MM; van der Flier WM
    J Alzheimers Dis; 2010; 22(1):87-95. PubMed ID: 20847452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parkinson disease with REM sleep behavior disorder: features, α-synuclein, and inflammation.
    Hu Y; Yu SY; Zuo LJ; Cao CJ; Wang F; Chen ZJ; Du Y; Lian TH; Wang YJ; Chan P; Chen SD; Wang XM; Zhang W
    Neurology; 2015 Mar; 84(9):888-94. PubMed ID: 25663225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.